Bronchitol

Indicated For

Cystic Fibrosis

About This Medication

# Chiesi CareDirect Patient Assistance Program: How to Get Bronchitol at Low or No Cost ## About This Program The Chiesi CareDirect Patient Assistance Program provides financial assistance for eligible patients who cannot afford Bronchitol (mannitol inhalation powder). Bronchitol is a medication designed to help clear mucus from the lungs, improve lung function, and reduce exacerbations in patients with cystic fibrosis.[1] This program ensures that cost is not a barrier to accessing this important treatment. ## About Bronchitol Bronchitol is an inhaled powder medication containing mannitol that works by helping to mobilize and clear mucus from the airways. The medication comes in 40 mg capsules that are loaded individually into an inhaler device—the capsules must never be swallowed.[5] The standard recommended dose is 400 mg (10 capsules) inhaled twice daily, in the morning and evening, with the evening dose taken two to three hours before bedtime.[5] Before starting Bronchitol, patients must undergo an initiation dose assessment performed by a qualified healthcare professional in a medical setting where breathing can be monitored. This assessment involves gradually increasing doses up to 400 mg total to check for bronchial hyper-responsiveness, a condition in which airways narrow easily. Patients showing this response cannot be treated with Bronchitol.[5] The most common side effect is cough, occurring in more than 1 in 10 patients.[5] More serious but rare side effects include bronchospasm (airway narrowing) during the initiation assessment and hemoptysis (coughing up blood) during treatment.[5] ## Who Qualifies for Assistance To be eligible for the Chiesi CareDirect Patient Assistance Program, you must meet all of the following requirements: - Be a legal U.S. resident[1] - Have no prescription drug coverage for Bronchitol through insurance, Medicare, Medicaid, or other third-party payers[1] - Not qualify for federal, state, or private insurance reimbursement for Bronchitol[1] - Have a valid prescription from your healthcare provider[1] - Demonstrate financial need based on household income[1] If you have insurance but face a 100% co-insurance responsibility after your deductible is met, you may still qualify for assistance.[1] ## Income Eligibility The search results do not specify exact income thresholds for the Chiesi CareDirect program. However, the program requires applicants to provide proof of household income through one of the following documents:[1] - Federal Tax Return - Pay stubs - Bank statements showing deposits - Social Security or disability statements - Other documentation of yearly household income When you apply, include whichever income documentation is most current and representative of your household's financial situation. If you do not file taxes, alternative income documentation is acceptable.[1] ## Insurance Requirements You cannot have any prescription coverage for Bronchitol through: - Private insurance plans - Medicare - Medicaid - State pharmaceutical assistance programs - Other third-party payers[1] The program is specifically designed for uninsured patients or those whose insurance does not cover this medication. If your insurance denies coverage or you have exhausted your coverage options, you may become eligible for this assistance program.[1] ## How to Apply: Step-by-Step **Step 1: Gather Required Documents** Before starting your application, collect the following:[1] - A valid prescription for Bronchitol from your healthcare provider - Proof of household income (tax return, pay stubs, bank statements, or disability/Social Security statements) - Proof of U.S. residency **Step 2: Complete the Application Form** Obtain the Chiesi CareDirect Patient Assistance Program Application form. The form requires:[1] - Your full name and contact information - Today's date - Your healthcare provider's information (name, DEA number, state license number, office contact, phone, fax, and email) - Selection of which medication you're requesting (Bronchitol or Pertzye) - Dosing instructions and quantity needed **Step 3: Sign the Certification Section** You must sign and date the Patient Certification and Authorization to Disclose Information section. Your signature is valid for one year from the date you sign.[1] **Step 4: Attach Supporting Documents** Attach to your application:[1] - A copy of your household's Federal Tax Return, or alternative income documentation if you don't file taxes - A valid prescription for Bronchitol **Step 5: Submit Your Application** Submit your completed application with all attachments. The search results do not specify the exact submission method (mail, fax, online portal, or phone). Contact Chiesi USA directly for current submission instructions and the application form. ## Timeline and Medication Delivery The search results do not specify the processing timeline for applications or the method by which medication is delivered to approved patients. Contact Chiesi USA directly to ask about: - How long approval typically takes - Whether medications are mailed directly to your home or pharmacy - How refills are handled - Whether you need to reapply annually ## What If Your Application Is Denied? If your application is denied, ask Chiesi USA for the specific reason. Common reasons for denial include: - Having active prescription insurance coverage for Bronchitol - Not meeting income requirements - Incomplete application or missing documentation - Not being a legal U.S. resident If denied, ask whether you can reapply if your circumstances change, such as losing insurance coverage or experiencing a change in household income. ## Important Notes **FDA Approval Status:** Bronchitol is approved for marketing in Australia (ages 6+) and throughout the European Union (ages 18+).[6] However, as of the most recent available information, Bronchitol has not received FDA approval for marketing in the United States, though it has been granted Orphan Drug designation for cystic fibrosis treatment.[6] **Program Availability:** Verify that this patient assistance program is currently active by contacting Chiesi USA before applying. ## Disclaimer This guide provides general information about the Chiesi CareDirect Patient Assistance Program based on available program documentation. Program details, eligibility requirements, and application procedures may change. For the most current and complete information, contact Chiesi USA directly or visit their official website. This guide is not a substitute for official program materials or professional medical advice. Always consult with your healthcare provider about your treatment options and eligibility for assistance programs.

Program information last verified: March 30, 2026